Volume 3, Number 2—June 1997
Synopsis
Rhodococcus equi and Arcanobacterium haemolyticum: Two "Coryneform" Bacteria Increasingly Recognized as Agents of Human Infection
Regina Linder
Table 1
Rhodococcus equi case reports in humans: 1967-1996
| Years | Cases | Predisposing condition (number) | Primary site of infection (number) | Deaths | Referencesa |
|---|---|---|---|---|---|
| 1967-76 | 7 | Corticosteroid (1) | Lung (6) | 0 | 8-10 |
| Cancer/immunosuppressant (3) | Lymphatic (1) | ||||
| Renal transplant (2) | |||||
| Noneb (1) | |||||
| 1977-86 | 15 | Corticosteroid (1) | Lung (14) | 8 | 8-10,22 |
| Cancer/immunosuppressant (4) | Blood (1) | ||||
| Renal transplant (2) | |||||
| HIV (7) | |||||
| Alcoholism (1) | |||||
| 1987-96 | 93 | Cancer/immunosuppressant (8) | Lung (72) | 34 | 8-13,22 |
| Renal transplant (3) | Lymphatic (2) | ||||
| HIV (67) | Blood (8) | ||||
| Otherc (8) (1b) | Wound (6) | ||||
| None (7) (4b) | Otherd (5) |
aIn the interest of space, case compilations are cited in lieu of individual case reports.
bChild
cIncludes intravenous drug use, lab infection, emphysema, kidney disease.
dCentral nervous system, gastrointestinal
